HRAS and ductal breast carcinoma in situ: In addition, all cell lines in the MCF10 series are reliant on growth factor supplementation suggesting that the proliferation of variants harboring the T24-H-Ras, such as MCF10.DCIS, is not driven entirely by this oncogene.